Turning Point Brands (TPB) reported Q4 2025 results with total consolidated net sales of USD 121.0 million (+29.2%), gross profit of USD 67.7 million (+29.1%), and net income of USD 8.2 million (+239.8%). Q4 adjusted EBITDA was USD 30.0 million (+14.4%). Diluted EPS was USD 0.42 and adjusted diluted EPS was USD 0.95. For FY 2025, TPB posted total consolidated net sales of USD 463.1 million (+28.4%), gross profit of USD 264.3 million (+31.1%), and net income of USD 58.2 million (+46.1%). FY adjusted EBITDA was USD 119.5 million (+14.4%), with diluted EPS of USD 3.11 and adjusted diluted EPS of USD 3.96. In Q4, Stoker’s segment net sales were USD 81.0 million (+69.5%), driven by triple-digit growth in Modern Oral sales, while Zig-Zag segment net sales were USD 40.0 million (-12.8%) amid the planned wind-down of the Clipper business and a shift of sales and marketing resources to white pouch. Q4 consolidated SG&A rose to USD 47.7 million (+38.2%), including USD 1.1 million of FDA PMTA-related expenses. TPB ended 2025 with cash of USD 222.8 million, net debt of USD 77.2 million and total liquidity of USD 290.1 million. For 2026, management expects Modern Oral gross revenue of USD 220-240 million and net revenue of USD 180-190 million, and forecasts Q1 2026 adjusted EBITDA of USD 24-27 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Turning Point Brands Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260302348296) on March 02, 2026, and is solely responsible for the information contained therein.